Last reviewed · How we verify
PNB Bupivacaine
At a glance
| Generic name | PNB Bupivacaine |
|---|---|
| Also known as | Marcaine |
| Sponsor | Mayo Clinic |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Sacral Erector Spinae Plane Block Versus Penile Block For Analgesia In Pediatric Circumcision (NA)
- Nerve Block for Pain Control After Fracture Surgery (NA)
- Anesthesia And Post-operative Mortality After Proximal Femur Fractures (NA)
- Ultrasound-guided PNB and DPNB for Pediatric Distal Hypospadias Surgery
- Pudendal Nerve Block for Post-Episiotomy Pain Relief (PHASE3)
- Total Hip Arthroplasty (THA) Lumbar Plexus Verses Periarticular (PHASE4)
- Pudendal Nerve Block for Postoperative Posterior Repair Pain Relief (PHASE2)
- Peripheral Nerve Blocks vs Periarticular Local Anesthetic Injection for Total Knee Arthroplasty (TKA) (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PNB Bupivacaine CI brief — competitive landscape report
- PNB Bupivacaine updates RSS · CI watch RSS
- Mayo Clinic portfolio CI